Edition 001 — Available now

Theranos

The $9B lie that taught Silicon Valley nothing.

Founder psychology Board accountability Healthcare fraud Charisma vs. competence
$19 one-time purchase — instant access
Get the full report Secure checkout · 20% goes to Nexara
5,000+ words
Sourced & cited
16 min read
It was October 2015, and Elizabeth Holmes was standing on a stage at a Wall Street Journal conference. She'd just been told her company's flagship product didn't work.
The board you recruit is the board you deserve.
"We're very proud of it" is not a response to evidence.
Secrecy is not the same as focus.
The lie doesn't scale — it compounds.
Charisma is not a substitute for competence.
Unlock the full report

Six sections. Zero fluff.

01

The Moment

Where we open — Holmes at the WSJ conference in October 2015, four months before Forbes dropped her net worth to zero. The scene sets the entire story.

02

The Origin

19-year-old Stanford dropout. Channing Robertson's gamble. Real-Time Cures becomes Theranos. $6M raised in 14 months. The pitch that seduced the world.

03

The Product That Never Worked

The Edison ran 12 tests — not 200. Siemens machines running patient samples. A scientist who tried to raise the alarm and was ignored. Ian Gibbons dies by suicide in 2014.

04

How It Scaled

Kissinger. Shultz. Mattis. The most impressive board in American corporate history — and the most useless as oversight. Tyler Shultz, George Shultz's grandson, finds the fraud. Walgreens spends $350M. Safeway does the same.

05

The Unraveling

John Ioannidis publishes in JAMA. Carreyrou publishes in the WSJ. CMS finds "immediate jeopardy to patient health." FDA warning letters. Walgreens exits. The company voids two years of results. Fortress loans $100M to keep it alive.

06

Five Lessons for Founders

Board accountability, response to evidence, secrecy vs. focus, compounding lies, and the difference between charisma and competence. Concrete, applicable, uncomfortable.

"You know, people try to take advantage of situations like this. We know what we're doing and we're very proud of it."

— Elizabeth Holmes, Wall Street Journal conference, October 2015

Four months later, Forbes dropped her net worth from $4.5 billion to zero.

$19
Buy now — instant access
Edition 001 — Theranos

Get the full teardown.

One-time purchase. Instant access. No subscription required.

Full 5,000+ word report — six sections
Five concrete lessons for founders
Primary sources & citations
16-minute read — save and reference it
Total $19
Get instant access — $19

Powered by Stripe · Secure checkout · Nexara keeps 80%

Not ready to buy? Get the free preview instead.

Free first edition · Then $10/month to continue · Cancel anytime

Is this a subscription?

No. This is a one-time purchase. Pay $19, access the report forever. No recurring charges.

How do I access the report after buying?

After payment, you'll receive an email with a link to your report. You'll also get access to the full archive if you subscribe to the weekly newsletter later.

What's the difference between this and the newsletter?

The newsletter delivers one new teardown per week for $10/month. This report is the standalone, permanent version of the Theranos edition — available now without a subscription.

Can I get a refund?

If the report doesn't meet your expectations, email dev@nexara.io within 7 days and we'll make it right.